KINIKSA PHARMACEUTICALS LTD

CUSIP: G5269C101 Class: Foreign Stock

D. E. Shaw & Co., Inc.'s Holding History (CIK: 0001009207)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 221,853 Value ($000) $4,377 Avg Close — Range —
Q4 2023
Shares 304,605 Value ($000) $5,343 Avg Close — Range —
Q3 2023
Shares 317,519 Value ($000) $5,515 Avg Close — Range —
Q2 2023
Shares 238,600 Value ($000) $3,359 Avg Close — Range —
Q1 2023
Shares 239,788 Value ($000) $2,580 Avg Close — Range —
Q4 2022
Shares 237,445 Value ($000) $3,557 Avg Close — Range —
Q3 2022
Shares 112,171 Value ($000) $1,440 Avg Close — Range —
Q2 2022
Shares 42,928 Value ($000) $416 Avg Close — Range —
Q4 2021
Shares 12,317 Value ($000) $145 Avg Close — Range —
Q4 2020
Shares 50,089 Value ($000) $885 Avg Close — Range —
Q3 2020
Shares 102,386 Value ($000) $1,569 Avg Close — Range —
Q2 2020
Shares 49,382 Value ($000) $1,258 Avg Close — Range —
Q2 2019
Shares 26,134 Value ($000) $354 Avg Close — Range —
Q1 2019
Shares 95,256 Value ($000) $1,720 Avg Close — Range —
Q4 2018
Shares 9,542 Value ($000) $268 Avg Close — Range —